女人张开腿让男人添,在线?亚洲?国产 欧美,嫩草乱码一区三区四区,特级做A爰片毛片免费69

Expert forum

首頁 專家論壇 標(biāo)本專家Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring bre
注冊

Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring bre

2017-12-08 08:07來源:原版作者:Satelli A

BACKGROUND:

Detection, isolation, and enumeration of circulating tumor cells (CTCs) from cancer patients has become an important modality in clinical management of patients with breast cancer. Although CellSearch, an epithelial cell adhesion molecule (EpCAM)-based method that is used to isolate epithelial CTCs, has gained prominence, its inability to detect mesenchymal CTCs from breast cancer patients raises concerns regarding its utility in clinical management.

METHODS:

To address this gap in technology, we recently discovered the utility of cell-surface vimentin (CSV) as a marker for detecting mesenchymal CTCs from sarcoma tumors. In the present study, we tested the sensitivity and specificity of detecting CTCs from blood collected at a random time during therapy from each of 58 patients with metastatic breast cancer by use of 84-1 (a monoclonal antibody against CSV to detect epithelial/mesenchymal-transition CTCs) and CellSearch methods. Additionally, we tested the possibility of improving the sensitivity and specificity of detection by use of additional parameters including nuclear EpCAM localization and epithelial mesenchymal ratios.

RESULTS:

CTC counts with CSV were significant (P = 0.0053) in differentiating populations responsive and nonresponsive to treatment compared with CTC counts with CellSearch (P = 0.0564). The specificity of CTC detection was found to be highest when the sum of CTC counts from the 2 methods was above a threshold of 8 CTCs/7.5 mL.

CONCLUSIONS:

The sum of CTC counts from the CellSearch and CSV methods appears to provide new insights for assessment of therapeutic response and thus provides a new approach to personalized medicine in breast cancer patients.

(Clin Chem. 2015 Jan;61(1):259-66. )

版權(quán)聲明:

本網(wǎng)站所有注明“來源:“陽普醫(yī)療”的文字、圖片和音視頻資料,版權(quán)均屬于陽普醫(yī)療所有,非經(jīng)授權(quán),任何媒體、網(wǎng)站或個人不得轉(zhuǎn)載,授權(quán)轉(zhuǎn)載時須注明

“來源:陽普醫(yī)療”。本網(wǎng)所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們聯(lián)系,我們將立即進(jìn)行刪除處理。

網(wǎng)友評論:

  • <center id="wvtgz"><tr id="wvtgz"><track id="wvtgz"></track></tr></center>
  • <ul id="wvtgz"></ul>

      
      
        1. 主站蜘蛛池模板: 海安县| 依安县| 惠来县| 鲁甸县| 安龙县| 天津市| 通道| 祁东县| 内乡县| 岫岩| 田东县| 囊谦县| 偏关县| 肇州县| 邹城市| 伊金霍洛旗| 临邑县| 香河县| 宜都市| 巢湖市| 灵石县| 灵台县| 遵义市| 图片| 平度市| 普定县| 宁城县| 南雄市| 汤阴县| 江孜县| 邵东县| 营口市| 宝兴县| 建阳市| 资溪县| 民县| 乐东| 云和县| 遂昌县| 灵宝市| 花垣县|